183 related articles for article (PubMed ID: 35733175)
21. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
[TBL] [Abstract][Full Text] [Related]
22. Combining single-cell RNA sequencing data and transcriptomic data to unravel potential mechanisms and signature genes of the progression of idiopathic pulmonary fibrosis to lung adenocarcinoma and predict therapeutic agents.
Zhou X; Tan F; Zhang S; Zhang T
Funct Integr Genomics; 2023 Nov; 23(4):346. PubMed ID: 37996625
[TBL] [Abstract][Full Text] [Related]
23. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
24. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
Fei H; Chen S; Xu C
Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
[TBL] [Abstract][Full Text] [Related]
25. Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism.
Hou Y; Yang Z; Xiang B; Liu J; Geng L; Xu D; Zhan M; Xu Y; Zhang B
Sci Rep; 2024 May; 14(1):12406. PubMed ID: 38811809
[TBL] [Abstract][Full Text] [Related]
26. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
27. FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
Luo L; Li M; Su J; Yao X; Luo H
Clin Exp Med; 2022 Aug; 22(3):371-384. PubMed ID: 34510311
[TBL] [Abstract][Full Text] [Related]
28. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
30. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19.
Yang L; Xiong H; Li X; Li Y; Zhou H; Lin X; Chan TF; Li R; Lai KP; Chen X
Front Nutr; 2022; 9():870370. PubMed ID: 35520289
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
32. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
Front Immunol; 2022; 13():992626. PubMed ID: 36311724
[TBL] [Abstract][Full Text] [Related]
33. Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.
Liu D; Lin S; Li Y; Zhou T; Hu K; Li Q
Drug Des Devel Ther; 2022; 16():375-395. PubMed ID: 35210754
[TBL] [Abstract][Full Text] [Related]
34. Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods.
Gao L; Li GS; Li JD; He J; Zhang Y; Zhou HF; Kong JL; Chen G
Comput Struct Biotechnol J; 2021; 19():6229-6239. PubMed ID: 34840672
[TBL] [Abstract][Full Text] [Related]
35. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma.
Bian D; Chen Y
Comput Math Methods Med; 2022; 2022():3918926. PubMed ID: 35844446
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics Identification of Key Genes for the Development and Prognosis of Lung Adenocarcinoma.
Luo X; Xu JG; Wang Z; Wang X; Zhu Q; Zhao J; Bian L
Inquiry; 2022; 59():469580221096259. PubMed ID: 35635202
[TBL] [Abstract][Full Text] [Related]
38. Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E.
Kumar R; Afsar M; Khandelwal N; Chander Y; Riyesh T; Dedar RK; Gulati BR; Pal Y; Barua S; Tripathi BN; Hussain T; Kumar N
Antiviral Res; 2021 May; 189():105056. PubMed ID: 33711336
[TBL] [Abstract][Full Text] [Related]
39. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]